Bispecific antibody capable of binding to cd40 and gpc3
WO2020189781A1
Agent for treating parkinson's disease
WO2020166557A1
Method for treating pregancy-induced hypertension nephrosis
TW202039581A
Bispecific antibody binding to TfR
TW202031684A
Fn14 antibodies and uses thereof
WO2020111280A1
Nucleic acid complex
TW202038918A
Pharmaceutical composition
WO2020091041A1
Liquid medium preparation method
TW202021611A
Pharmaceutical composition for treating aplastic anemia
WO2020067541A1
Antibody composition
WO2020065594A1
Il-36 antibodies and uses thereof
AU2019295277A1
Antibody binding to chondroitin sulfate proteoglycan-5
KR20210027295A
Antibodies that bind to cell adhesion molecule 3
JP2020189805A
Method for producing orally disintegrable tablet
TW202030202A
Anti-BMP10 antibody and therapeutic agent using the antibody as effective component for treating hypertension and hypertensive diseases containing an antagonist for at least one of BMP10 and BMP9/BMP10 heterogeneous dimers to treat hypertension and hypertensive disease
